Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6032
Source ID: NCT00690638
Associated Drug: Phx1149t
Title: Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: PHX1149T|DRUG: PHX1149T|DRUG: Placebo
Outcome Measures: Primary: To demonstrate changes in HbA1c, Day 28 to Day 196 |
Sponsor/Collaborators: Sponsor: Phenomix | Collaborators: Forest Laboratories
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 480
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2008-07
Completion Date: 2010-04
Results First Posted:
Last Update Posted: 2010-04-13
Locations: Norwalk, California, United States|Orange, California, United States|Santa Ana, California, United States|Daytona Beach, Florida, United States|Kissimmee, Florida, United States|Atlanta, Georgia, United States|Honolulu, Hawaii, United States|Brockton, Massachusetts, United States|St. Louis, Missouri, United States|Cincinnati, Ohio, United States|El Paso, Texas, United States|San Antonio, Texas, United States|Norfolk, Virginia, United States|Caba, Buenos Aires, Argentina|La Plata, Buenos Aires, Argentina|Lanús, Buenos Aires, Argentina|Paraná, Entre Ríos, Argentina|Rosario, Santa Fé, Argentina|Corrientes, Argentina|Salta, Argentina|Hyderabad, Andhara Pradesh, India|Bangalore, Karnataka, India|Gulbarga, Karnataka, India|Mumbai, Maharashtra, India|Nagpur, Maharashtra, India|Nashik, Maharashtra, India|Navi Mumbai, Maharashtra, India|Pune, Maharashtra, India|Chennai, Tamil Nadu, India|Kelantan, Malaysia|Kuala Lumpur, Malaysia|Perak, Malaysia|Sarawak, Malaysia|Arequipa, Arequipa Region, Peru|Chiclayo-Lambayeque, Chiclayo, Peru|Cercado de Lima, Lima, Peru|Lince, Lima, Peru|San Isisdro, Lima, Peru|San Miguel, Lima, Peru|Manila, NCR, Philippines|Quezon City, NCR, Philippines|San Juan, NCR, Philippines|Cebu City, VII, Philippines|Jud. Brasov, Brasov, Romania|Sector 1, Bucharest, Romania|Sector 2, Bucharest, Romania|Brasov, Romania|Galati, Romania|Ploiesti, Romania|Sibiu, Romania|Ratchatavi, Bangkok, Thailand|Muang, Khon Kaen, Thailand|Simferopol, Crimean Autonomy Republic, Ukraine|2A Postysheva Pr., Kharkov, Ukraine|Ivano-Frankivsk, Ukraine|Kharkiv, Ukraine|Kiev, Ukraine|Kyiv, Ukraine|Lviv, Ukraine|Poltava, Ukraine|Vinnytsa, Ukraine|Zaporizhzhia, Ukraine
URL: https://clinicaltrials.gov/show/NCT00690638